Terasaki Institute Innovation: our moonshot factory
We help solve some of the world’s hardest problems in health leveraging our rapid translational process
Moonshots to Measurable Impacts:
We prioritize bold ideas with real-world potential. With our legacy of having pioneered the field of transplant immunology, our programs align with clinical partners, demonstrate a clear path to patient benefit, and offer quantifiable reductions in disease burden measured through DALYs . We back high-risk, high-reward biomedical innovations grounded in three principles:
Significant Clinical Impact
Significant Clinical Impact
Project addresses a clear unmet medical need or solves an important clinical problem.
Innovative and Differentiated Solution
Innovative and Differentiated Solution
Projects introduce a novel approach or technology and provide unique value to address unmet clinical needs.
Translatable Health Outcomes
Translatable Health Outcomes
Projects demonstrate high DALY (Disability-Adjusted Life Year) impact. DALY is a widely used metric in public health and health economics. It measures the overall disease burden by combining the impact of premature death and years lived with disability.
Our Strategic Positioning:
We provide seed funding for programs that develop proof of concepts
We develop key platforms to enable rapid translation
We partner to incubate and build impactful companies
We collaborate with industry to commercialize innovation
We have a unique agile process for innovation assessment and have a collaborative ecosystem to accelerate translational projects in collaboration with key clinical, academic, incubation and venturing partners.
We leverage our state-of-the-art research core facility and key research platforms to help de-risk novel research towards the creation of tomorrow's disruptive solutions.
Our process is a problem-first approach where we bring focus to gaps in science and technology and focus solutions to those gaps.
Explore Innovation Licensing Opportunities
Biomaterials
Biomaterials
Bio and Wearable Sensors
Bio and Wearable Sensors
Physiological Models
Physiological Models
Engineered Cells
Engineered Cells
Partner with us?
Benefits of Partnering with us:
● Accelerated Translation
● Access to Interdisciplinary Ecosystem
● Reduced Development Timeline
● Impact on Society
● Access to enabling core platforms
● Access to core facilities and labs
.png)
Industry
Industry
Accelerated Innovation, Reduced R&D Risk, Access to Specialized Technologies, Talent Pipelines, Clinical Relevance & Validation, Shared Resources & Cost Efficiency, Co-ownership of IP, Licensing of IP, Start-up formation and incubation
Academic
Academic
Amplified Research Impact, Joint Funding Opportunities, Access to Specialized Technologies, Collaborative Publications & Career Development, Stronger Network
Foundations and Donors
Foundations and Donors
Enhanced Impact, Measurable Outcomes, Matched Investments, Long-Term Legacy, Program Related Investment (PRI) with mission alignment
Our Innovation Team
Contact us at partner@Terasaki.org
Maurizio Vecchione
Chief Innovation Officer | mvecchione@terasaki.orgMaurizio Vecchione
Chief Innovation Officer | mvecchione@terasaki.org
Mehmet R. Dokmeci
Innovation Faculty | mdokmeci@terasaki.orgMehmet R. Dokmeci
Innovation Faculty | mdokmeci@terasaki.org
Shengli Ding
Program Manager | shengli.ding@terasaki.orgShengli Ding
Program Manager | shengli.ding@terasaki.org
Menekse Ermis
Innovation Faculty | mermis@terasaki.orgMenekse Ermis
Innovation Faculty | mermis@terasaki.org